The US Patent and Trademark Office (USPTO) announced that it is accepting, and waiving the fee for, petitions to advance the initial examination of trademark applications for certain COVID-19 medical products and services.
To qualify for the advanced examination procedure, applicants must seek registration for a mark for:
Pharmaceutical products or medical devices that prevent, diagnose, treat, or cure COVID-19 and are subject to approval by the US Food and Drug Administration, such as:
diagnostic tests;
ventilators; and
personal protective equipment.
Medical services or medical research services for the prevention, diagnosis, treatment of, or cure for COVID-19.
The application may also include additional, related, goods or services.
After filing a qualifying application, applicants should file a petition to the Director under 37 C.F.R. 2.146(a)(3):
Seeking to advance the initial examination of the application out of regular order.
Accompanied by an affidavit or declaration explaining how the application's goods or services are related to COVID-19.
If the petition is granted, the application will be assigned to an examining attorney for review immediately, which should expedite examination by approximately two months.